Biotech and Pharmaceuticals
Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.
Moderna logo is seen in Warsaw, Poland on April 9, 2025. Jakub Porzycki | Nurphoto | Getty Images Moderna on Friday lowered the high end of its 2025 revenue outlook due to a delay in vaccine shipments to the U.K., but beat Wall Street’s expectations for the second quarter as it works to cut costs. […]
Read More
Trump’s drug price ultimatum sets pharma firms scrambling
Key Points A fresh ultimatum demanding “binding commitments” to lower U.S. drug prices sent pharma firms scrambling Friday. President Trump sent letters to 17 major firms outlining the steps they must take to cut costs. Healthcare stocks tumbled Friday, following broader market losses as investors digested Trump’s amended tariffs. Pharmaceutical firms are scrambling to respond […]
Read More
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, David Sacks, AI & Crypto Czar and Amy Gleason, Acting Administrator, Department of Government Efficiency (DOGE) attend the “Making Health Technology Great Again” event in the East Room […]
Read More
Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity
Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024. Nurphoto | Nurphoto | Getty Images Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company’s […]
Read More
CVS shares pop on earnings beat and outlook, as retail pharmacy and insurance units improve
CVS Health on Thursday reported second-quarter earnings and revenue that topped estimates and raised its adjusted profit outlook, as it sees strength in its retail pharmacy business and some improvement in its insurance unit. Shares of the retail drugstore chain jumped more than 9% in premarket trading Thursday. The company now expects fiscal 2025 adjusted […]
Read More
Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow
The Moderna Inc. headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna on Thursday said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine market. […]
Read More
Pandemic darlings Moderna, BioNTech are now on two different paths
A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies are on different paths. Both Moderna and BioNTech helped pioneer mRNA, or […]
Read More
Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
The office building of international biopharmaceutical company AstraZeneca. Cfoto | Future Publishing | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. President Donald Trump has been pressuring pharmaceutical companies to lower U.S. drug […]
Read More
Trump’s pharmaceutical tariffs could affect some drugmakers more than others
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer | Getty Images President Donald Trump is slated to impose tariffs on pharmaceuticals imported into the U.S. any day now – and the duties may have a bigger impact on some drugmakers than others, according to some […]
Read More
Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook
Merck & Co. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Tuesday, April 8, 2025. Michael Nagle | Bloomberg | Getty Images Merck on Tuesday said it will slash $3 billion in costs by the end of 2027 to be fully reinvested to support new product launches […]
Read More